<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>HEIM Framework | Health Equity Informative Metrics</title>
    <meta name="description" content="Health Equity Informative Metrics - measuring research equity gaps in biobanks and clinical trials relative to global disease burden">

    <!-- Chart.js -->
    <script src="https://cdn.jsdelivr.net/npm/chart.js@4.4.1/dist/chart.umd.min.js"></script>
    <script src="https://cdn.jsdelivr.net/npm/chartjs-plugin-datalabels@2.2.0/dist/chartjs-plugin-datalabels.min.js"></script>

    <!-- Styles -->
    <link rel="stylesheet" href="css/style.css">
</head>
<body>
    <!-- Header Banner -->
    <header class="header">
        <div class="header-content">
            <div class="header-title">
                <h1>HEIM Framework <span class="version">v3.0</span></h1>
                <p class="tagline">Health Equity Informative Metrics: Discovery + Translation + Knowledge</p>
            </div>
            <div class="header-meta">
                <span class="framework-badge">Three-Dimensional Equity Analysis</span>
                <div class="dimension-badges">
                    <span class="dim-badge dim-discovery">Discovery</span>
                    <span class="dim-badge dim-translation">Translation</span>
                    <span class="dim-badge dim-knowledge">Knowledge</span>
                </div>
            </div>
        </div>
    </header>

    <!-- Navigation Tabs -->
    <nav class="nav-tabs">
        <button class="tab-btn active" data-tab="overview">Overview</button>
        <button class="tab-btn" data-tab="knowledge">Knowledge</button>
        <button class="tab-btn" data-tab="clinical-trials">Clinical Trials</button>
        <button class="tab-btn" data-tab="biobanks">Biobanks</button>
        <button class="tab-btn" data-tab="diseases">Diseases</button>
        <button class="tab-btn" data-tab="comparison">Pipeline Gap</button>
        <button class="tab-btn" data-tab="trends">Trial Trends</button>
        <button class="tab-btn" data-tab="equity">Equity</button>
        <button class="tab-btn" data-tab="about">About</button>
    </nav>

    <!-- Main Content -->
    <main class="main-content">

        <!-- Tab 1: Overview -->
        <section id="overview" class="tab-content active">
            <div class="section-header">
                <h2>The Architecture of Research Inequity</h2>
                <p>How disadvantage compounds across Discovery, Translation, and Knowledge</p>
            </div>

            <!-- Key Finding Banner - NTD Focus -->
            <div class="card key-finding-card">
                <div class="key-finding-icon">&#9888;</div>
                <div class="key-finding-content">
                    <h3>Key Finding</h3>
                    <p><strong>Neglected Tropical Diseases are structurally isolated</strong> in the research literature. NTDs show 20% higher semantic isolation than other diseases (p=0.002, Cohen's d=0.82), limiting their ability to benefit from advances in related fields. This isolation compounds existing funding and trial coverage gaps.</p>
                </div>
            </div>

            <!-- Three Pillars - Simplified Visual -->
            <div class="three-pillars">
                <div class="pillar pillar-discovery">
                    <div class="pillar-header">Discovery</div>
                    <div class="pillar-stat" id="stat-biobanks">70</div>
                    <div class="pillar-label">Biobanks analyzed</div>
                    <div class="pillar-finding"><span id="stat-critical">22</span> diseases with critical gaps</div>
                </div>
                <div class="pillar pillar-translation">
                    <div class="pillar-header">Translation</div>
                    <div class="pillar-stat" id="stat-ct-gap">2.4x</div>
                    <div class="pillar-label">Research intensity gap</div>
                    <div class="pillar-finding">Global South diseases get <span id="stat-ct-gs-pct">20%</span> of trials</div>
                </div>
                <div class="pillar pillar-knowledge">
                    <div class="pillar-header">Knowledge</div>
                    <div class="pillar-stat" id="stat-sem-diseases">176</div>
                    <div class="pillar-label">Diseases mapped semantically</div>
                    <div class="pillar-finding"><span id="stat-sem-isolated">8</span> diseases are research "islands"</div>
                </div>
            </div>

            <!-- Top 5 Most Neglected - Clean List -->
            <div class="card">
                <h3>Most Neglected Diseases</h3>
                <p class="card-description">Ranked by unified triple-burden score (combines all three dimensions)</p>
                <div class="top-five-list" id="top-neglected-unified">
                    <!-- Populated by JS -->
                </div>
            </div>

            <!-- Single Chart -->
            <div class="card chart-card">
                <h3>Research Intensity Gap</h3>
                <p class="card-description">Trials per million DALYs: Lowest vs Highest research attention</p>
                <div class="chart-container">
                    <canvas id="chart-intensity-compare"></canvas>
                </div>
            </div>

            <!-- Brief Methodology -->
            <div class="card info-card">
                <h3>About This Analysis</h3>
                <p><strong>HEIM v3.0</strong> integrates three data sources to reveal compound neglect:</p>
                <ul>
                    <li><strong>70 biobanks</strong> from the International HundredK+ Cohorts Consortium (Discovery)</li>
                    <li><strong>2.2M clinical trials</strong> from ClinicalTrials.gov (Translation)</li>
                    <li><strong>13.1M PubMed papers</strong> with PubMedBERT embeddings (Knowledge)</li>
                </ul>
                <p class="methodology-source">Corpas et al. (2026) - In preparation</p>
            </div>
        </section>

        <!-- Tab 2: Knowledge Structure (NEW) -->
        <section id="knowledge" class="tab-content">
            <div class="section-header">
                <h2>Knowledge Structure Analysis</h2>
                <p>Semantic analysis of PubMed papers revealing the architecture of research knowledge</p>
            </div>

            <!-- Semantic Summary Cards -->
            <div class="summary-cards">
                <div class="card summary-card sem-card">
                    <div class="card-value" id="sem-total-papers">--</div>
                    <div class="card-label">Papers Analyzed</div>
                    <div class="card-sublabel">2000-2025</div>
                </div>
                <div class="card summary-card sem-card">
                    <div class="card-value" id="sem-embeddings">--</div>
                    <div class="card-label">Embeddings Generated</div>
                    <div class="card-sublabel">PubMedBERT 768-dim</div>
                </div>
                <div class="card summary-card sem-card">
                    <div class="card-value" id="sem-diseases">--</div>
                    <div class="card-label">Diseases Analyzed</div>
                </div>
                <div class="card summary-card sem-card">
                    <div class="card-value" id="sem-unified-mean">--</div>
                    <div class="card-label">Mean Unified Score</div>
                </div>
            </div>

            <!-- Data Quality Notice -->
            <div class="card" style="background: #fef3c7; border-left: 4px solid #f59e0b; margin-bottom: 1.5rem;">
                <h3 style="color: #92400e;">&#9888; Data Quality Notice</h3>
                <p>The semantic analysis for some diseases has incomplete PubMed coverage due to search term limitations.
                Affected diseases include lung cancer, brain cancer, and Alzheimer's disease.
                Results for these diseases should be interpreted with caution. A data re-collection with improved MeSH term mapping is in progress.</p>
            </div>

            <!-- Key Insight - Statistically Validated -->
            <div class="card insight-card semantic-insight">
                <h3>&#129504; NTDs Are Structurally Isolated in Research</h3>
                <p><strong>17 WHO Neglected Tropical Diseases</strong> show significantly higher semantic isolation than other diseases:</p>
                <ul style="margin: 0.5rem 0 0.5rem 1.5rem;">
                    <li>Mean SII: 0.00242 vs 0.00201 (<strong>p=0.002</strong>, Cohen's d=0.82)</li>
                    <li>Lower Knowledge Transfer Potential (<strong>p=0.009</strong>)</li>
                    <li><strong>Guinea worm disease</strong> has the highest isolation (2x mean)</li>
                </ul>
                <p style="margin-top: 0.75rem;">This isolation limits NTDs' ability to benefit from advances in related fields, compounding existing funding gaps.</p>
            </div>

            <!-- Semantic Metrics Explanation -->
            <div class="card">
                <h3>Semantic Metrics Explained</h3>
                <div class="metrics-grid">
                    <div class="metric-box">
                        <h4>SII (Semantic Isolation Index)</h4>
                        <p>Measures how far a disease's research is from the centroid of all biomedical knowledge. Higher values indicate more isolated, siloed research.</p>
                        <div class="metric-interpretation"><strong>Interpretation:</strong> Diseases with high SII (top 25%) are research "islands" disconnected from mainstream science</div>
                    </div>
                    <div class="metric-box">
                        <h4>KTP (Knowledge Transfer Potential)</h4>
                        <p>Maximum similarity to any other disease. Lower values mean less opportunity to benefit from advances in related fields.</p>
                        <div class="metric-interpretation"><strong>Interpretation:</strong> Most diseases have high KTP (>99%), but even small differences indicate reduced spillover benefit</div>
                    </div>
                    <div class="metric-box">
                        <h4>RCC (Research Clustering Coefficient)</h4>
                        <p>Density of connections in the knowledge network. Lower values indicate sparser research communities.</p>
                        <div class="metric-interpretation"><strong>Interpretation:</strong> Low RCC diseases have fewer collaborating research fields and less integrated knowledge</div>
                    </div>
                    <div class="metric-box">
                        <h4>Unified Score (0-100)</h4>
                        <p>Combined neglect score integrating Discovery (biobank gaps), Translation (trial equity), and Knowledge (semantic isolation).</p>
                        <div class="metric-interpretation"><strong>Interpretation:</strong> Higher scores = more neglected. Top diseases score 40+ across all three dimensions</div>
                    </div>
                </div>
            </div>

            <!-- Knowledge Landscape Visualization -->
            <div class="card figure-card">
                <h3>Knowledge Landscape (UMAP Projection)</h3>
                <p class="card-description">2D projection of disease embeddings showing research clusters</p>
                <div class="figure-container">
                    <img id="fig-umap" src="" alt="UMAP Knowledge Landscape" class="analysis-figure">
                </div>
            </div>

            <div class="card figure-card">
                <h3>Knowledge Transfer Network</h3>
                <p class="card-description">Connections between diseases based on semantic similarity</p>
                <div class="figure-container">
                    <img id="fig-network" src="" alt="Knowledge Network" class="analysis-figure">
                </div>
            </div>

            <div class="card figure-card">
                <h3>Disease Similarity Heatmap</h3>
                <p class="card-description">Cross-disease semantic similarity matrix - darker colors indicate more related research</p>
                <div class="figure-container">
                    <img id="fig-heatmap" src="" alt="Semantic Similarity Heatmap" class="analysis-figure">
                </div>
            </div>

            <div class="card figure-card">
                <h3>Gap Score vs Semantic Isolation</h3>
                <p class="card-description">Correlation between biobank neglect and knowledge isolation</p>
                <div class="figure-container">
                    <img id="fig-gap-isolation" src="" alt="Gap vs Isolation" class="analysis-figure">
                </div>
            </div>

            <div class="card figure-card">
                <h3>Temporal Research Drift</h3>
                <p class="card-description">How research focus has shifted over 25 years</p>
                <div class="figure-container">
                    <img id="fig-temporal" src="" alt="Temporal Drift" class="analysis-figure">
                </div>
            </div>

            <!-- Disease Rankings Table -->
            <div class="card">
                <h3>Disease Semantic Metrics</h3>
                <p class="card-description">Complete metrics for all analyzed diseases, sorted by Unified Score</p>
                <div class="filters">
                    <input type="text" id="semantic-disease-search" class="search-input" placeholder="Search diseases...">
                    <select id="semantic-filter" class="filter-select">
                        <option value="all">All Diseases</option>
                        <option value="high-isolation">High Isolation (SII > 0.003)</option>
                        <option value="low-ktp">Low Transfer Potential</option>
                        <option value="top-unified">Top 20 Unified Score</option>
                    </select>
                </div>
                <div class="table-container">
                    <table class="data-table sortable" id="table-semantic-diseases">
                        <thead>
                            <tr>
                                <th>Disease</th>
                                <th>Papers</th>
                                <th>Gap Score</th>
                                <th>Isolation %</th>
                                <th>Transfer %</th>
                                <th>Clustering %</th>
                                <th>Unified</th>
                            </tr>
                        </thead>
                        <tbody></tbody>
                    </table>
                </div>
                <p class="table-note">Note: Isolation/Transfer/Clustering show percentile ranks (0-100%). Higher isolation = more neglected. Higher transfer = better connected.</p>
            </div>
        </section>

        <!-- Tab 3: Clinical Trials -->
        <section id="clinical-trials" class="tab-content">
            <div class="section-header">
                <h2>Clinical Trials Analysis</h2>
                <p>2.19 million trials from ClinicalTrials.gov (2000-2025) mapped to GBD disease categories</p>
            </div>

            <!-- CT Summary Cards -->
            <div class="summary-cards">
                <div class="card summary-card">
                    <div class="card-value" id="ct-total-trials">--</div>
                    <div class="card-label">Total Trials</div>
                </div>
                <div class="card summary-card">
                    <div class="card-value" id="ct-gs-trials">--</div>
                    <div class="card-label">GS Priority Trials</div>
                    <div class="card-sublabel" id="ct-gs-trials-pct">--</div>
                </div>
                <div class="card summary-card">
                    <div class="card-value" id="ct-intensity-gap">--</div>
                    <div class="card-label">Intensity Gap</div>
                    <div class="card-sublabel">non-GS vs GS</div>
                </div>
                <div class="card summary-card">
                    <div class="card-value" id="ct-neglected">--</div>
                    <div class="card-label">Severely Neglected</div>
                    <div class="card-sublabel">&lt;500 trials in 26 years</div>
                </div>
            </div>

            <!-- Cancer Dominance Alert -->
            <div class="card alert-card">
                <div class="alert-icon">&#9888;</div>
                <div class="alert-content">
                    <h4>Cancer Dominance Problem</h4>
                    <p><strong id="ct-cancer-pct">--</strong> of all clinical trials focus on cancers, which represent only <strong id="ct-cancer-burden-pct">--</strong> of global disease burden-a <strong id="ct-cancer-ratio">--</strong> overrepresentation.</p>
                </div>
            </div>

            <!-- Charts -->
            <div class="charts-row">
                <div class="card chart-card">
                    <h3>Trial Count by Disease Category</h3>
                    <div class="chart-container chart-large">
                        <canvas id="chart-ct-by-category"></canvas>
                    </div>
                </div>
                <div class="card chart-card">
                    <h3>Research Intensity by Category</h3>
                    <div class="chart-container chart-large">
                        <canvas id="chart-ct-intensity"></canvas>
                    </div>
                </div>
            </div>

            <!-- All Diseases Trial Coverage -->
            <div class="card">
                <h3>Disease Trial Coverage</h3>
                <p class="card-description">All diseases mapped to GBD categories with clinical trial coverage</p>
                <div class="table-container">
                    <table class="data-table sortable" id="table-ct-gs-diseases">
                        <thead>
                            <tr>
                                <th>Disease</th>
                                <th>Category</th>
                                <th>Trials</th>
                                <th>DALYs (M)</th>
                                <th>Intensity</th>
                                <th>Assessment</th>
                            </tr>
                        </thead>
                        <tbody></tbody>
                    </table>
                </div>
            </div>

            <!-- Geographic Distribution -->
            <div class="card">
                <h3>Geographic Distribution of Trial Sites</h3>
                <div class="charts-row">
                    <div class="chart-card-inner">
                        <h4>HIC vs LMIC Distribution</h4>
                        <div class="chart-container">
                            <canvas id="chart-ct-hic-lmic"></canvas>
                        </div>
                    </div>
                    <div class="chart-card-inner">
                        <h4>Top 15 Countries</h4>
                        <div class="chart-container chart-large">
                            <canvas id="chart-ct-countries"></canvas>
                        </div>
                    </div>
                </div>
            </div>

            <!-- Temporal Trends -->
            <div class="card">
                <h3>Temporal Trends (2000-2025)</h3>
                <div class="charts-row">
                    <div class="chart-card-inner">
                        <h4>Trial Volume Growth</h4>
                        <div class="chart-container">
                            <canvas id="chart-ct-temporal-volume"></canvas>
                        </div>
                    </div>
                    <div class="chart-card-inner">
                        <h4>GS Priority Share Over Time</h4>
                        <div class="chart-container">
                            <canvas id="chart-ct-temporal-gs"></canvas>
                        </div>
                    </div>
                </div>
                <div class="trend-insight">
                    <strong>Trend Insight:</strong> Despite a <span id="ct-growth-factor">--</span> increase in trial volume since 2000, the share of trials addressing Global South Priority diseases has <strong>declined</strong> by <span id="ct-gs-decline">--</span> percentage points.
                </div>
            </div>

            <!-- Lowest Intensity Diseases -->
            <div class="card">
                <h3>Lowest Research Intensity Diseases (&gt;5M DALYs)</h3>
                <p class="card-description">High-burden diseases receiving the least research attention</p>
                <div class="table-container">
                    <table class="data-table" id="table-ct-lowest-intensity">
                        <thead>
                            <tr>
                                <th>Disease</th>
                                <th>Trials/M DALYs</th>
                                <th>Total Trials</th>
                                <th>DALYs (M)</th>
                                <th>GS Priority</th>
                            </tr>
                        </thead>
                        <tbody></tbody>
                    </table>
                </div>
            </div>
        </section>

        <!-- Tab 3: Biobanks -->
        <section id="biobanks" class="tab-content">
            <div class="section-header">
                <h2>Biobank Analysis</h2>
                <p>Detailed equity metrics for each biobank in the International HundredK+ Cohorts Consortium (IHCC)</p>
            </div>

            <!-- Filters -->
            <div class="filters">
                <input type="text" id="biobank-search" class="search-input" placeholder="Search biobanks...">
                <select id="biobank-region-filter" class="filter-select">
                    <option value="">All Regions</option>
                    <option value="AFR">Africa</option>
                    <option value="AMR">Americas</option>
                    <option value="EMR">Eastern Mediterranean</option>
                    <option value="EUR">Europe</option>
                    <option value="SEAR">South-East Asia</option>
                    <option value="WPR">Western Pacific</option>
                </select>
                <select id="biobank-category-filter" class="filter-select">
                    <option value="">All Categories</option>
                    <option value="High">High Alignment</option>
                    <option value="Moderate">Moderate Alignment</option>
                    <option value="Low">Low Alignment</option>
                </select>
            </div>

            <!-- Biobanks Table -->
            <div class="card">
                <div class="table-container">
                    <table class="data-table sortable" id="table-biobanks">
                        <thead>
                            <tr>
                                <th data-sort="name">Biobank</th>
                                <th data-sort="country">Country</th>
                                <th data-sort="region">Region</th>
                                <th data-sort="eas">EAS</th>
                                <th data-sort="category">Category</th>
                                <th data-sort="publications">Publications</th>
                                <th data-sort="diseases">Diseases</th>
                                <th data-sort="gaps">Critical Gaps</th>
                            </tr>
                        </thead>
                        <tbody></tbody>
                    </table>
                </div>
            </div>

            <!-- Download Button -->
            <div class="actions">
                <button class="btn btn-primary" onclick="downloadBiobanksCSV()">Download CSV</button>
            </div>
        </section>

        <!-- Tab 4: Diseases -->
        <section id="diseases" class="tab-content">
            <div class="section-header">
                <h2>Disease Analysis</h2>
                <p>Research gaps by disease relative to global burden (GBD 2021)</p>
            </div>

            <!-- Filters -->
            <div class="filters">
                <input type="text" id="disease-search" class="search-input" placeholder="Search diseases...">
                <select id="disease-view-filter" class="filter-select">
                    <option value="all">All Diseases</option>
                    <option value="gs">Global South Priority Only</option>
                    <option value="neglected">Severely Neglected (&lt;500 trials)</option>
                </select>
            </div>

            <!-- Disease Chart -->
            <div class="card chart-card">
                <h3>Disease Burden vs Clinical Trial Coverage</h3>
                <div class="chart-container chart-large">
                    <canvas id="chart-disease-scatter"></canvas>
                </div>
            </div>

            <!-- Diseases Table -->
            <div class="card">
                <div class="table-container">
                    <table class="data-table sortable" id="table-diseases">
                        <thead>
                            <tr>
                                <th>Disease</th>
                                <th>Category</th>
                                <th>DALYs (M)</th>
                                <th>Clinical Trials</th>
                                <th>Intensity</th>
                                <th>GS Priority</th>
                            </tr>
                        </thead>
                        <tbody></tbody>
                    </table>
                </div>
            </div>
        </section>

        <!-- Tab 5: Pipeline Comparison -->
        <section id="comparison" class="tab-content">
            <div class="section-header">
                <h2>Discovery-to-Translation Gap</h2>
                <p>Comparing equity patterns between biobank research and clinical trials</p>
            </div>

            <!-- Comparison Summary -->
            <div class="comparison-table-card card">
                <h3>Pipeline Stage Comparison</h3>
                <table class="comparison-table">
                    <thead>
                        <tr>
                            <th>Metric</th>
                            <th>Biobanks (Discovery)</th>
                            <th>Clinical Trials (Translation)</th>
                            <th>Interpretation</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>HIC:LMIC Ratio</strong></td>
                            <td>57.8:1 (publications)</td>
                            <td id="comp-hic-ratio">--</td>
                            <td class="interpretation-good">Better in trials</td>
                        </tr>
                        <tr>
                            <td><strong>Cancer Focus</strong></td>
                            <td>~42% of publications</td>
                            <td id="comp-cancer-focus">--</td>
                            <td class="interpretation-bad">Worse in trials</td>
                        </tr>
                        <tr>
                            <td><strong>GS Priority Share</strong></td>
                            <td>~15% of research</td>
                            <td id="comp-gs-share">--</td>
                            <td class="interpretation-moderate">Slightly better</td>
                        </tr>
                        <tr>
                            <td><strong>Temporal Trend</strong></td>
                            <td>Slowly improving</td>
                            <td id="comp-trend">Declining (-12.3 pp)</td>
                            <td class="interpretation-bad">Worsening</td>
                        </tr>
                    </tbody>
                </table>
            </div>

            <!-- Key Insight -->
            <div class="card insight-card">
                <h3>&#128161; Key Insight: The Pipeline Paradox</h3>
                <p>While <strong>geographic concentration is better</strong> in clinical trials (2.5:1 vs 57.8:1 HIC:LMIC ratio), <strong>disease priorities are worse</strong>. Cancer research dominates trials even more than biobank publications (61.5% vs 42%), suggesting that while trials are more geographically accessible, research agendas remain skewed toward high-income country priorities.</p>
            </div>

            <!-- Consistently Neglected -->
            <div class="card">
                <h3>Consistently Neglected Diseases</h3>
                <p class="card-description">Diseases under-researched at BOTH discovery and translation stages</p>
                <div class="neglected-diseases-grid" id="neglected-diseases-grid">
                    <!-- Populated by JS -->
                </div>
            </div>
        </section>

        <!-- Tab 6: Trends -->
        <section id="trends" class="tab-content">
            <div class="section-header">
                <h2>Clinical Trial Trends</h2>
                <p>How translation-stage research equity has evolved (2000-2025)</p>
            </div>

            <div class="card chart-card">
                <h3>Clinical Trial Volume Growth</h3>
                <div class="chart-container chart-large">
                    <canvas id="chart-trends-ct-growth"></canvas>
                </div>
            </div>

            <div class="card chart-card">
                <h3>Global South Priority Share Over Time</h3>
                <div class="chart-container chart-large">
                    <canvas id="chart-trends-gs-share"></canvas>
                </div>
            </div>

            <div class="card info-card">
                <h3>Trend Analysis</h3>
                <p><strong>2000-2005 average:</strong> 47.7% of trials addressed GS priority diseases</p>
                <p><strong>2020-2025 average:</strong> 35.5% of trials addressed GS priority diseases</p>
                <p><strong>Change:</strong> <span class="trend-negative">-12.3 percentage points</span></p>
                <p>Despite a <strong>15.5x increase</strong> in total trial volume, the share dedicated to Global South Priority diseases has <em>declined</em>. The COVID-19 pandemic temporarily increased GS share (43.1% in 2020) but this was transient.</p>
            </div>
        </section>

        <!-- Tab 7: Equity -->
        <section id="equity" class="tab-content">
            <div class="section-header">
                <h2>Research Equity Summary</h2>
                <p>Key inequities across the three dimensions of the research pipeline</p>
            </div>

            <!-- Three Dimension Equity Summary -->
            <div class="equity-dimensions">
                <div class="equity-dim">
                    <h4>Discovery (Biobanks)</h4>
                    <div class="equity-stat">57.8:1</div>
                    <div class="equity-label">HIC vs LMIC publication ratio</div>
                    <p class="equity-detail">High-income country biobanks produce 58x more research output than LMIC biobanks</p>
                </div>
                <div class="equity-dim">
                    <h4>Translation (Trials)</h4>
                    <div class="equity-stat" id="equity-ct-ratio">2.5:1</div>
                    <div class="equity-label">HIC vs LMIC trial site ratio</div>
                    <p class="equity-detail">Global South diseases get 20% of trials despite 38% of disease burden</p>
                </div>
                <div class="equity-dim">
                    <h4>Knowledge (Semantic)</h4>
                    <div class="equity-stat">8</div>
                    <div class="equity-label">Semantically isolated diseases</div>
                    <p class="equity-detail">Neglected diseases exist as research "islands" disconnected from mainstream science</p>
                </div>
            </div>

            <!-- Key Insight -->
            <div class="card alert-card">
                <div class="alert-icon">&#9888;</div>
                <div class="alert-content">
                    <h4>The Compounding Effect</h4>
                    <p>Inequity worsens at each stage: diseases under-studied in biobanks are also under-represented in trials AND semantically isolated. This creates self-reinforcing cycles where neglected diseases receive progressively less attention.</p>
                </div>
            </div>

            <!-- Charts -->
            <div class="charts-row">
                <div class="card chart-card">
                    <h3>Burden vs Research Allocation</h3>
                    <p class="card-description">Global South diseases: 38% of burden, 20% of trials</p>
                    <div class="chart-container">
                        <canvas id="chart-equity-burden-research"></canvas>
                    </div>
                </div>
                <div class="card chart-card">
                    <h3>Trial Site Distribution</h3>
                    <p class="card-description">Where clinical trials are conducted globally</p>
                    <div class="chart-container">
                        <canvas id="chart-equity-geo"></canvas>
                    </div>
                </div>
            </div>

            <!-- What This Means -->
            <div class="card info-card">
                <h3>What This Means</h3>
                <p>The three-dimensional analysis reveals that research inequity is not random but <strong>structural</strong>. The same diseases that are neglected in one dimension tend to be neglected across all dimensions, suggesting systemic factors that perpetuate the gap.</p>
                <p>Addressing this requires interventions at multiple levels: funding priorities, trial site selection, and deliberate efforts to connect isolated research communities to mainstream biomedical science.</p>
            </div>
        </section>

        <!-- Tab 8: About -->
        <section id="about" class="tab-content">
            <div class="section-header">
                <h2>About HEIM Framework</h2>
                <p>Methodology, data sources, and how to interpret this dashboard</p>
            </div>

            <!-- What is HEIM -->
            <div class="card methodology-card">
                <h3>&#127919; What is HEIM?</h3>
                <p><strong>HEIM (Health Equity Informative Metrics)</strong> is a comprehensive framework for measuring alignment between biomedical research output and global health priorities. It quantifies the "discovery-to-translation gap"-showing how health equity disparities persist and even worsen as research moves from basic science (biobanks) to clinical application (trials).</p>
                <p>The framework answers critical questions:</p>
                <ul>
                    <li>Are we studying the diseases that cause the most suffering?</li>
                    <li>Do Global South populations benefit equitably from research?</li>
                    <li>Is the situation improving or worsening over time?</li>
                </ul>
            </div>

            <!-- Data Sources -->
            <div class="card methodology-card">
                <h3>&#128202; Data Sources</h3>

                <div class="methodology-subsection">
                    <h4>Clinical Trials Data (Translation)</h4>
                    <p>Trial data comes from <a href="https://clinicaltrials.gov/" target="_blank">ClinicalTrials.gov</a> via the AACT database (Aggregate Analysis of ClinicalTrials.gov).</p>
                    <ul>
                        <li><strong>563,725 studies</strong> retrieved (2000-2025)</li>
                        <li><strong>2,189,930 disease-trial mappings</strong> (trials can address multiple diseases)</li>
                        <li><strong>770,178 trial site records</strong> across 194 countries</li>
                    </ul>
                </div>

                <div class="methodology-subsection">
                    <h4>Disease Burden Data</h4>
                    <p>Burden data from <a href="https://www.healthdata.org/gbd/2021" target="_blank">Global Burden of Disease Study 2021</a> (IHME).</p>
                    <ul>
                        <li><strong>DALYs (Disability-Adjusted Life Years)</strong>: One DALY = one year of healthy life lost</li>
                        <li><strong>89 disease categories</strong> mapped to GBD Level 3 causes</li>
                        <li><strong>29 Global South Priority diseases</strong> identified based on WHO criteria and LMIC burden distribution</li>
                    </ul>
                </div>

                <div class="methodology-subsection">
                    <h4>Biobank Data (Discovery)</h4>
                    <p>Publication data from PubMed for 70 biobanks in the <a href="https://ihccglobal.org/" target="_blank">IHCC registry</a>.</p>
                </div>

                <div class="methodology-subsection">
                    <h4>PubMed Semantic Data (Knowledge)</h4>
                    <p>Abstracts retrieved from <a href="https://pubmed.ncbi.nlm.nih.gov/" target="_blank">PubMed</a> (2000-2025) using MeSH terms and keyword searches. Embeddings generated using <a href="https://huggingface.co/microsoft/BiomedNLP-PubMedBERT-base-uncased-abstract-fulltext" target="_blank">PubMedBERT</a>.</p>
                    <ul>
                        <li><strong>13,100,113 papers</strong> retrieved for 176 diseases</li>
                        <li><strong>13,100,113 embeddings</strong> generated (768-dimensional dense vectors)</li>
                        <li><strong>176 diseases</strong> with sufficient data for analysis</li>
                    </ul>
                </div>
            </div>

            <!-- Key Metrics -->
            <div class="card methodology-card">
                <h3>&#128208; Key Metrics Explained</h3>

                <div class="methodology-subsection">
                    <h4>Research Intensity</h4>
                    <div class="formula-box">
                        <code>Research Intensity = Trials (or Publications) / Million DALYs</code>
                    </div>
                    <p>Measures research attention relative to disease burden. Higher = more research per unit of suffering.</p>
                </div>

                <div class="methodology-subsection">
                    <h4>Intensity Gap</h4>
                    <div class="formula-box">
                        <code>Intensity Gap = Non-GS Intensity / GS Priority Intensity</code>
                    </div>
                    <p>Ratio of research intensity between non-Global South diseases and GS Priority diseases. A value of 2.4x means non-GS diseases receive 2.4 times more research attention per DALY.</p>
                </div>

                <div class="methodology-subsection">
                    <h4>Global South Priority Diseases</h4>
                    <p>29 diseases identified based on WHO classification criteria and GBD 2021 burden distribution:</p>
                    <ul>
                        <li><strong>WHO Neglected Tropical Diseases:</strong> Chagas, Dengue, Leishmaniasis, Lymphatic filariasis, Malaria, Onchocerciasis, Schistosomiasis, Trachoma, etc.</li>
                        <li><strong>Major infectious diseases:</strong> TB, HIV/AIDS, Lower respiratory infections, Diarrheal diseases, Meningitis</li>
                        <li><strong>Maternal and neonatal:</strong> Maternal disorders, Neonatal disorders</li>
                        <li><strong>Nutritional:</strong> Protein-energy malnutrition, Dietary iron deficiency</li>
                    </ul>
                    <p>Selection based on diseases where >60% of global DALYs occur in low- and middle-income countries.</p>
                </div>

                <div class="methodology-subsection">
                    <h4>Semantic Isolation Index (SII)</h4>
                    <div class="formula-box">
                        <code>SII = mean(cosine_distance(disease_embedding, global_centroid))</code>
                    </div>
                    <p>Measures how far a disease's research is from the center of all biomedical knowledge. Higher SII indicates more isolated research that doesn't benefit from mainstream advances.</p>
                </div>

                <div class="methodology-subsection">
                    <h4>Knowledge Transfer Potential (KTP)</h4>
                    <div class="formula-box">
                        <code>KTP = max(cosine_similarity(disease_i, disease_j)) for all j ≠ i</code>
                    </div>
                    <p>Maximum similarity to any other disease. Higher KTP means the disease can potentially benefit from advances in related fields.</p>
                </div>

                <div class="methodology-subsection">
                    <h4>Unified Triple-Burden Score</h4>
                    <div class="formula-box">
                        <code>Unified = 0.33×Discovery + 0.33×Translation + 0.34×Knowledge</code>
                    </div>
                    <p>Combines Gap Score (biobanks), Clinical Trial Equity, and Semantic Isolation into a single measure of compound neglect. Higher scores indicate diseases facing disadvantage across multiple dimensions.</p>
                    <p><strong>Weighting justification:</strong> Equal weights are used because the three dimensions are empirically orthogonal (inter-dimension correlation r=0.07), meaning they capture independent aspects of neglect rather than redundant signals. This orthogonality supports treating them as equally important contributors to overall disadvantage.</p>
                </div>
            </div>

            <!-- Statistical Validation -->
            <div class="card methodology-card">
                <h3>&#128202; Statistical Validation</h3>
                <p>The central finding - that NTDs are semantically isolated - was validated using multiple statistical approaches:</p>

                <div class="methodology-subsection">
                    <h4>NTD Semantic Isolation</h4>
                    <table class="comparison-table" style="margin: 1rem 0;">
                        <thead>
                            <tr><th>Metric</th><th>NTDs (n=17)</th><th>Non-NTDs (n=129)</th><th>p-value</th></tr>
                        </thead>
                        <tbody>
                            <tr><td>Mean SII</td><td>0.00242</td><td>0.00201</td><td><strong>0.002</strong></td></tr>
                            <tr><td>Mean KTP</td><td>0.9987</td><td>0.9989</td><td><strong>0.009</strong></td></tr>
                            <tr><td>Mann-Whitney U</td><td colspan="2">U=1715</td><td><strong>0.0001</strong></td></tr>
                        </tbody>
                    </table>
                    <p><strong>Effect size:</strong> Cohen's d = 0.82 (large effect). The orthogonality of dimensions (r=0.07) confirms they measure independent aspects of neglect.</p>
                </div>
            </div>

            <!-- Policy Implications -->
            <div class="card methodology-card">
                <h3>&#127919; Policy Implications</h3>
                <p>The identification of semantic isolation as a measurable dimension of neglect suggests actionable interventions:</p>
                <ul>
                    <li><strong>Targeted funding mechanisms:</strong> Prioritize semantically isolated diseases (high SII) for cross-disciplinary research initiatives</li>
                    <li><strong>Research network building:</strong> Fund collaborative projects that explicitly connect NTD researchers with mainstream biomedical science</li>
                    <li><strong>WHO monitoring:</strong> Consider adopting SII as a complementary indicator alongside traditional R&D metrics</li>
                    <li><strong>Knowledge translation:</strong> Develop systematic reviews that explicitly bridge isolated disease literature with related therapeutic areas</li>
                </ul>
                <p>The finding that isolation is <em>measurable</em> means progress can be tracked - providing accountability for equity-focused research investments.</p>
            </div>

            <!-- Limitations -->
            <div class="card methodology-card">
                <h3>&#9888; Limitations</h3>
                <ul>
                    <li><strong>Data sources:</strong> ClinicalTrials.gov has US/Western registration bias; PubMed has English-language bias</li>
                    <li><strong>Biobank coverage:</strong> 70 IHCC biobanks may not represent all global biobank activity</li>
                    <li><strong>Temporal scope:</strong> Embeddings trained on 2000-2025 literature; historical patterns may differ</li>
                    <li><strong>Generalizability:</strong> The NTD finding is robust; broader framework applicability requires further validation</li>
                </ul>
            </div>

            <!-- Citation -->
            <div class="card methodology-card">
                <h3>&#128218; Citation</h3>
                <div class="citation-box">
                    <p><strong>Corpas M, Valdivia-Silva J, Fatumo S, Baker S, Guio H.</strong> (2026). Health Equity Informative Metrics (HEIM): Quantifying the Discovery-to-Translation Gap in Global Health Research. <em>In preparation</em>.</p>
                </div>
                <p>Source code and data: <a href="https://github.com/manuelcorpas/17-EHR" target="_blank">github.com/manuelcorpas/17-EHR</a></p>
            </div>

            <!-- Contact -->
            <div class="card methodology-card">
                <h3>&#128231; Contact</h3>
                <p><strong>Manuel Corpas</strong> - <a href="mailto:m.corpas@westminster.ac.uk">m.corpas@westminster.ac.uk</a></p>
                <p>University of Westminster | The Alan Turing Institute | GENEQ Global</p>
            </div>
        </section>

    </main>

    <!-- Footer -->
    <footer class="footer">
        <div class="footer-content">
            <p>
                <strong>HEIM Framework v3.0</strong> |
                Data: GBD 2021, ClinicalTrials.gov, PubMed, PubMedBERT Embeddings |
                <a href="https://github.com/manuelcorpas/17-EHR" target="_blank">GitHub</a>
            </p>
            <p class="footer-methodology">
                Corpas et al. (2026) - Three-Dimensional Health Equity Analysis
            </p>
        </div>
    </footer>

    <!-- Scripts -->
    <script src="js/app.js"></script>
    <script src="js/charts.js"></script>
</body>
</html>
